English | Español
Gene Johnson | Mar 9, 2017

Sigma-Tau Pharmaceuticals changes name to Leadiant Biosciences
Gene Johnson | Mar 9, 2017

Ferring, Foresee Pharmaceuticals enter exclusive development deal
Robert Lawson | Mar 9, 2017

AMA writes amicus brief to support proper medical testimony
Gene Johnson | Mar 9, 2017

FDA approves Qtern for treatment of Type 2 diabetes
Gene Johnson | Mar 9, 2017

Aurinia Pharmaceuticals CEO speaks at health care conference
Gene Johnson | Mar 9, 2017

Registration open for National Psoriasis Foundation's biennial conference

Gene Johnson | Mar 9, 2017

Survey shows diabetics unaware of increased risk for serious illnesses
Erianne Leatherman | Mar 8, 2017

Study reveals adolescents with Type 2 diabetes more susceptible to complications

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access